ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Small Cell Lung Carcinoma
Cancer
Colorectal Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Breast Cancer

Lung Cancer trials near Barcelona, CT, ESP:

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Inhibitor( TKI) , to recurrent, advanced, or metastatic small cell lung cancer (SCLC) patients , Non-Small Cell Lung (NSCL...

Enrolling
Small Cell Lung Cancer
Non-Small Cell Lung
Drug: AL8326 40 mg
Drug: AL8326 60 mg

Phase 2

Advenchen

Barcelona, Spain and 6 other locations

(PFS) for the treatment of first-line stage IV non-small cell lung cancer (NSCLC) patients, leading to such combinations becoming a...

Enrolling
NSCLC (advanced Non-small Cell Lung Cancer)
Stage IV Lung Cancer
Drug: CIS-DPI

Phase 1, Phase 2

Inhatarget Therapeutics

Barcelona, Spain and 14 other locations

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Barcelona, Spain and 90 other locations

The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.

Enrolling
Extensive Stage Small Cell Lung Cancer
Drug: Tarlatamab

Phase 1

Amgen
Amgen

Barcelona, Catalonia, Spain and 30 other locations

The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...

Active, not recruiting
Advanced Non-Small Cell Lung Cancer
Drug: Docetaxel
Drug: Zimberelimab

Phase 2

Gilead Sciences
Gilead Sciences

Barcelona, Spain and 50 other locations

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Barcelona, Spain and 210 other locations

over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non-sma ...

Active, not recruiting
HER2 Mutant Non-small Cell Lung Cancer
HER2-positive Metastatic Breast Cancer
Drug: ELVN-002
Drug: Trastuzumab emtansine

Phase 1

Enliven Therapeutics

Barcelona, Spain and 38 other locations

Locations recently updated

Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common fo ...

Enrolling
Non-small Cell Lung Cancer
Drug: Pemetrexed
Biological: HER3-DXd

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Barcelona, Spain and 40 other locations

This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...

Active, not recruiting
Non-Small Cell Lung Cancer Metastatic
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Drug: Patritumab Deruxtecan (Fixed dose)
Drug: Patritumab Deruxtecan (Up-Titration)

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Barcelona, Spain and 123 other locations

The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The aims of this study are to see how safe an...

Active, not recruiting
Advanced Non-Small Cell Lung Cancer
Drug: Cemiplimab
Drug: BNT116

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Badalona, Barcelona, Spain and 52 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems